Human diploid MRC-5 cells exhibit several critical properties of human umbilical cord-derived mesenchymal stem cells (Q38969351)

8 September 2017

title

Human diploid MRC-5 cells exhibit several critical properties of human umbilical cord-derived mesenchymal stem cells (English)

1 reference

human umbilical cord mesenchymal stem cell

8 September 2017

main subject

1 reference

Kehua Zhang

1

1 reference

8 September 2017

Tao Na

2

1 reference

8 September 2017

Lin Wang

3

1 reference

8 September 2017

Qiang Gao

4

1 reference

8 September 2017

Weidong Yin

5

1 reference

8 September 2017

Junzhi Wang

6

1 reference

8 September 2017

Bao-Zhu Yuan

7

1 reference

8 September 2017

language of work or name

English

0 references

publication date

30 July 2014

1 reference

8 September 2017

1 reference

8 September 2017

volume

32

1 reference

8 September 2017

issue

50

1 reference

8 September 2017

page(s)

6820-6827

1 reference

The status of human diploid cell strain MRC-5 as an approved substrate for the production of viral vaccines

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.071

Characteristics of a human diploid cell designated MRC-5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.071

Phenotypic and genomic analysis of serotype 3 Sabin poliovirus vaccine produced in MRC-5 cell substrate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.071

Preparation and immunogenicity of an inactivated hepatitis A vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.071

[The usefulness of human lung embryonal fibroblast cells (MRC-5) for isolation of enteroviruses and adenoviruses]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.071

Mesenchymal stem cells for clinical application

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.071

Mesenchymal stromal cells: sensors and switchers of inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.071

Multilineage potential of adult human mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.071

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.071

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.071

Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.071

Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.071

Wharton's jelly mesenchymal stem cells as candidates for beta cells regeneration: extending the differentiative and immunomodulatory benefits of adult mesenchymal stem cells for the treatment of type 1 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.071

Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.071

Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.071

Indoleamine 2,3-dioxygenase and tumor-induced tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.071

Fetal mesenchymal stem cells derived from human umbilical cord sustain primitive characteristics during extensive expansion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.071

Study of oncogenic transformation in ex vivo expanded mesenchymal cells, from paediatric bone marrow.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.071

Differentiation of human umbilical cord mesenchymal stem cells into hepatocyte-like cells by hTERT gene transfection in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.071

Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.071

Use of the intracellular fluorescent dye CFSE to monitor lymphocyte migration and proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.071

Good manufacturing practices production of mesenchymal stem/stromal cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.071

Monitoring the biology stability of human umbilical cord-derived mesenchymal stem cells during long-term culture in serum-free medium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.071

Genetic stability of bone marrow-derived human mesenchymal stromal cells in the Quantum System

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.071

10.1016/J.VACCINE.2014.07.071

7 January 2021

Identifiers

DOI

1 reference

release_mhk5natolvbyhev2x5sfascb4a

8 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mhk5natolvbyhev2x5sfascb4a

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference